206 related articles for article (PubMed ID: 17116124)
1. Substitution of phenylephrine for pseudoephedrine as a nasal decongeststant. An illogical way to control methamphetamine abuse.
Eccles R
Br J Clin Pharmacol; 2007 Jan; 63(1):10-4. PubMed ID: 17116124
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of oral decongestants.
Kanfer I; Dowse R; Vuma V
Pharmacotherapy; 1993; 13(6 Pt 2):116S-128S; discussion 143S-146S. PubMed ID: 7507589
[TBL] [Abstract][Full Text] [Related]
3. Nasal decongestants in monotherapy for the common cold.
Deckx L; De Sutter AI; Guo L; Mir NA; van Driel ML
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD009612. PubMed ID: 27748955
[TBL] [Abstract][Full Text] [Related]
4. The advent of a new pseudoephedrine product to combat methamphetamine abuse.
Brzeczko AW; Leech R; Stark JG
Am J Drug Alcohol Abuse; 2013 Sep; 39(5):284-90. PubMed ID: 23968171
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of phenylephrine.
Desjardins PJ; Berlin RG
Br J Clin Pharmacol; 2007 Oct; 64(4):555-6; author reply 557. PubMed ID: 17610531
[No Abstract] [Full Text] [Related]
6. Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study.
Meltzer EO; Ratner PH; McGraw T
J Allergy Clin Immunol Pract; 2015; 3(5):702-8. PubMed ID: 26143019
[TBL] [Abstract][Full Text] [Related]
7. Comparative oral and topical decongestant effects of phenylpropanolamine and d-pseudoephedrine.
Erickson CH; McLeod RL; Mingo GG; Egan RW; Pedersen OF; Hey JA
Am J Rhinol; 2001; 15(2):83-90. PubMed ID: 11345158
[TBL] [Abstract][Full Text] [Related]
8. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold.
Jawad SS; Eccles R
Rhinology; 1998 Jun; 36(2):73-6. PubMed ID: 9695162
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
10. Acute ischaemic colitis associated with oral phenylephrine decongestant use.
Ward PW; Shaneyfelt TM; Roan RM
BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24895387
[TBL] [Abstract][Full Text] [Related]
11. SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.
Storms WW; Bodman SF; Nathan RA; Chervinsky P; Banov CH; Dockhorn RJ; Jarmoszuk I; Zeitz HJ; McGeady SJ; Pinnas JL
J Allergy Clin Immunol; 1989 Jun; 83(6):1083-90. PubMed ID: 2471718
[TBL] [Abstract][Full Text] [Related]
12. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant].
Teng Y; Zhang X; Xu G; Cai Q; Xu J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber.
Horak F; Zieglmayer P; Zieglmayer R; Lemell P; Yao R; Staudinger H; Danzig M
Ann Allergy Asthma Immunol; 2009 Feb; 102(2):116-20. PubMed ID: 19230461
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
Chervinsky P; Nayak A; Rooklin A; Danzig M
Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis.
Zieglmayer UP; Horak F; Toth J; Marks B; Berger UE; Burtin B
Treat Respir Med; 2005; 4(4):283-7. PubMed ID: 16086601
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold.
Kollar C; Schneider H; Waksman J; Krusinska E
Clin Ther; 2007 Jun; 29(6):1057-70. PubMed ID: 17692721
[TBL] [Abstract][Full Text] [Related]
17. Nasal decongestant activity of pseudoephedrine.
Roth RP; Cantekin EI; Bluestone CD; Welch RM; Cho YW
Ann Otol Rhinol Laryngol; 1977; 86(2 pt. 1):235-42. PubMed ID: 322570
[TBL] [Abstract][Full Text] [Related]
18. Selecting a decongestant.
Hendeles L
Pharmacotherapy; 1993; 13(6 Pt 2):129S-134S; discussion 143S-146S. PubMed ID: 7507590
[TBL] [Abstract][Full Text] [Related]
19. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
Eccles R; Martensson K; Chen SC
Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
[TBL] [Abstract][Full Text] [Related]
20. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
